People. Deals. Growth.

Astorg Mid Cap to acquire Barkene, a leading multi-specialist B2B technical services platform

Astorg Portfolio Company Solabia accelerates expansion plan with three strategic acquisitions

Astorg and Nordic Capital Announce Agreement to Sell Clario to Thermo Fisher Scientific

Astorg-backed Redslim acquires CatMan Solution to create a global data powerhouse

Astorg partners with ATTIKON, a Leading German Commercial Insurance Brokerage Platform

Montagu and Astorg welcome LGT Capital Partners as minority shareholder in Nemera

Astorg Strengthens Mid-Cap Team with New Head of France and Benelux

Astorg Announces Leadership Evolution to Drive Next Phase of Growth

Astorg to Acquire Solabia, a Leading Biotech Ingredient Solutions Provider

IQ-EQ enters the ANZ market with AMAL Group acquisition

Astorg Unveils, Nexpring Health, the New Brand Identity of its Global MedTech Company in Assisted Reproductive Technology

Astorg Announces Partner and Managing Director Promotions

Astorg Continues to Bolster its Newly Combined Global Leader in Assisted Reproductive Technology by Acquiring FUJIFILM Irvine Scientific’s Medical Media Business

Astorg Completes Take Private of Hamilton Thorne and Concurrent Acquisition of Cook Medical Reproductive Health, Establishing a Global Leader in Assisted Reproductive Technology Consumables and Equipment

Astorg Enters into Exclusive Negotiations to Sell its Majority Stake in Anaqua to Nordic Capital

Astorg Mid-Cap to invest in Redslim in partnership with its Founders and Management Team

Astorg Expands its Portfolio Performance Team with Two Senior Hires

Astorg enters into exclusive negotiations to invest in Lebronze alloys in partnership with its controlling family and management team

CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe

Astorg raises a €1.4 billion Continuation Fund in partnership with CVC Secondary Partners, Pantheon, Lexington Partners and Eurazeo to support portfolio company Normec

Astorg Increases Investment in Acturis alongside its Founders and Management

Astorg Strengthens Investment Team with Two Senior Hires

Astorg announces final closing for Astorg VIII, reaching total capital committed of €4.4bn. Astorg expands its Executive Committee

FNTC America, Ltd. (FNTCA) Announces acquisition of White Rock Group, LLC and the merger of Hayes, Johnson & Conley P.L.L.C with Eck, Collins & Richardson, PL

Astorg to Acquire a Majority Stake in Steliau

Astorg Announces Four New Senior Hires

Astorg Mid-Cap to invest in Sofico in partnership with its founders and Apheon

Normec acquired DETS & Latis, solidifying its leading position in the UK environmental testing market and further strengthening its pan-European leadership within the TICC sector

Astorg Pursues its Development and Strengthens its Team with Four Senior Hires

Astorg VIII Reaches €4 Billion At Interim Closing

IQ-EQ acquires Lymon PTE and ComplianceAsia

Fastmarkets demerges from Delinian

Astorg Mid-Cap acquires a majority stake in hg medical

Normec to partner with i2 Analytical and i2 FAST, strengthening its position as a pan-European leader within the TICC sector

Solina Acquires Canada's Lynch Foods

Astorg ranked in the top 20 performers globally & 5th best Europe-focused large buyout performer in the 2022 HEC-Dow Jones Large Buyout Performance Ranking

Astorg Partner Promotions Announced

IQ-EQ's UK Regulatory Compliance business expands with acquisition of Laven Compliance Ltd

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

Euromoney Institutional Investor PLC (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris

Solina to acquire Saratoga Food Specialties

Astorg announces its Board Diversity ambition

IQ-EQ expands its U.S. business with the acquisition of JGM Fund Services

IGM Resins Strengthens Market-Leading Position by Acquiring Litian

OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital